Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial - Chart
- Upturn Summary
- Highlights
- Valuation
- About
OPRX 
OPTIMIZERx Corp (OPRX)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- 1Y
- 1M
- 1W
Upturn Advisory Summary
12/26/2025: OPRX (2-star) is currently NOT-A-BUY. Pass it for now.
Upturn Star Rating
Below Average Performance
These Stocks/ETFs, based on Upturn Advisory, often underperform the market, warranting careful consideration before investing.
Number of Analysts
7 Analysts rated it
Limited analyst coverage, niche firm, research info may be scarce.
1 Year Target Price $24.33
1 Year Target Price $24.33
| 4 | Strong Buy |
| 2 | Buy |
| 1 | Hold |
| 0 | Sell |
| 0 | Strong Sell |
Analysis of Past Performance
Type Stock | Historic Profit 61.63% | Avg. Invested days 42 | Today’s Advisory PASS |
Upturn Star Rating | Upturn Advisory Performance  4.0 | Stock Returns Performance  3.0 |
| Profits based on simulation | Last Close 12/26/2025 |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 232.64M USD | Price to earnings Ratio 1248 | 1Y Target Price 24.33 |
Price to earnings Ratio 1248 | 1Y Target Price 24.33 | ||
Volume (30-day avg) 7 | Beta 1.1 | 52 Weeks Range 3.99 - 22.25 | Updated Date 12/28/2025 |
52 Weeks Range 3.99 - 22.25 | Updated Date 12/28/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) 0.01 |
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin 0.03% | Operating Margin (TTM) 7.86% |
Management Effectiveness
Return on Assets (TTM) 2.52% | Return on Equity (TTM) 0.03% |
Valuation
Trailing PE 1248 | Forward PE 13.87 | Enterprise Value 241724336 | Price to Sales(TTM) 2.12 |
Enterprise Value 241724336 | Price to Sales(TTM) 2.12 | ||
Enterprise Value to Revenue 2.21 | Enterprise Value to EBITDA 20.76 | Shares Outstanding 18640652 | Shares Floating 14277994 |
Shares Outstanding 18640652 | Shares Floating 14277994 | ||
Percent Insiders 15.54 | Percent Institutions 75.01 |
Upturn AI SWOT
OPTIMIZERx Corp
Company Overview
History and Background
OPTIMIZERx Corp. (formerly known as RxActive, Inc.) was founded in 2007. It initially focused on providing prescription savings programs. The company has evolved to offer a broader suite of digital health and patient support solutions, aiming to improve adherence and access to medications for patients. Key milestones include strategic partnerships and the expansion of its technology platform to integrate with healthcare provider workflows.
Core Business Areas
- Patient Support and Adherence Solutions: OPTIMIZERx offers a platform that connects patients, healthcare providers, and pharmaceutical manufacturers. This includes solutions for prescription savings, financial assistance programs, adherence reminders, and educational content to help patients manage their conditions and treatments effectively.
- Digital Engagement and Data Analytics: The company provides digital tools for healthcare providers to engage with patients, streamline administrative tasks, and gain insights into patient behavior and treatment adherence. This also involves offering data analytics to pharmaceutical companies to understand patient journeys and program effectiveness.
Leadership and Structure
OPTIMIZERx is led by a management team comprising experienced professionals in healthcare, technology, and pharmaceuticals. The organizational structure is designed to support its core business functions, including product development, sales and marketing, client services, and operations.
Top Products and Market Share
Key Offerings
- Product Name 1: Digital Savings and Assistance Programs. Description: This core offering provides patients with immediate access to prescription savings coupons and information about financial assistance programs for their medications. It aims to reduce out-of-pocket costs and improve affordability. Competitors include companies like GoodRx, SingleCare, and manufacturer-specific coupon programs. Market share data is not publicly disclosed but is a significant driver of the company's revenue.
- Product Name 2: Patient Adherence and Engagement Platform. Description: This suite of digital tools helps healthcare providers manage patient outreach, send adherence reminders, and provide educational resources. It also facilitates communication between providers and patients regarding treatment plans. Competitors include various patient relationship management (PRM) and electronic health record (EHR) integrated patient engagement solutions. Market share is nascent and growing within specific therapeutic areas.
Market Dynamics
Industry Overview
OPTIMIZERx operates in the digital health and pharmaceutical services market, specifically focusing on patient access, affordability, and adherence solutions. This industry is characterized by increasing healthcare costs, a growing demand for personalized patient experiences, and the expansion of digital technologies within healthcare. Key trends include the rise of value-based care, the need for better chronic disease management, and the adoption of telehealth and remote patient monitoring.
Positioning
OPTIMIZERx is positioned as a technology-driven platform that bridges the gap between pharmaceutical manufacturers, healthcare providers, and patients. Its competitive advantages lie in its established network of healthcare providers, its proprietary technology platform that integrates into provider workflows, and its ability to deliver personalized patient support at scale.
Total Addressable Market (TAM)
The total addressable market for patient support, adherence, and access solutions is substantial and growing, estimated to be in the tens of billions of dollars globally. This includes prescription savings, copay assistance, patient support programs, and digital health engagement. OPTIMIZERx is positioned to capture a segment of this TAM by leveraging its existing provider network and expanding its service offerings to address a wider range of patient needs.
Upturn SWOT Analysis
Strengths
- Established relationships with healthcare providers.
- Proprietary technology platform integrating into EHRs.
- Focus on improving patient adherence and access.
- Scalable business model.
- Experienced management team.
Weaknesses
- Reliance on pharmaceutical manufacturers for program funding.
- Competition from established players and new entrants.
- Challenges in demonstrating ROI to all stakeholders.
- Potential for regulatory changes impacting drug pricing and patient assistance.
Opportunities
- Expansion into new therapeutic areas and chronic conditions.
- Growth in digital health adoption by providers and patients.
- Leveraging data analytics for personalized patient interventions.
- Partnerships with payers and health systems.
- International market expansion.
Threats
- Changes in healthcare policy and reimbursement models.
- Increased competition and pricing pressures.
- Data security and privacy concerns.
- Economic downturns affecting healthcare spending.
- Disruption from new technologies.
Competitors and Market Share
Key Competitors
- GoodRx Holdings, Inc. (GDRX)
- Welldoc, Inc. (Private)
- Livongo Health (now part of Teladoc Health - TDOC)
- Insulet Corporation (PODD)
Competitive Landscape
OPTIMIZERx faces competition from both large, established companies and smaller, niche players. Its advantage lies in its deep integration with healthcare provider workflows and its focus on adherence solutions. However, competitors like GoodRx have a strong consumer brand and broader prescription savings reach. Teladoc Health, through its Livongo acquisition, has a significant presence in chronic condition management. OPTIMIZERx needs to continue innovating and demonstrating clear value propositions to maintain and grow its market share.
Growth Trajectory and Initiatives
Historical Growth: OPTIMIZERx has experienced historical growth in its revenue, driven by the expansion of its client base and service offerings. The company has been focused on scaling its platform and increasing its reach within the healthcare ecosystem.
Future Projections: Analyst estimates for OPTIMIZERx's future growth generally project continued revenue expansion, supported by the increasing demand for digital health solutions and patient support services. Projections often consider the company's ability to secure new partnerships and expand its product suite. Consensus estimates suggest revenue growth for FY2024 and FY2025.
Recent Initiatives: Recent initiatives include strengthening its digital platform, expanding its sales and marketing efforts to reach more healthcare providers and pharmaceutical partners, and exploring new product development opportunities in areas such as patient education and remote monitoring.
Summary
OPTIMIZERx Corp. operates in the growing digital health and patient support sector, demonstrating consistent revenue growth driven by its provider network and platform. Its strengths lie in its technology integration and focus on patient adherence. However, the company faces significant competition and reliance on pharmaceutical funding, alongside potential regulatory hurdles. Continued innovation and strategic partnerships will be crucial for sustained profitability and market position.
Similar Stocks
Sources and Disclaimers
Data Sources:
- OPTIMIZERx Corp. Investor Relations Filings (SEC)
- Financial News Outlets (e.g., Bloomberg, Reuters)
- Industry Research Reports
- Company Website
Disclaimers:
This analysis is based on publicly available information and is intended for informational purposes only. It does not constitute financial advice. Market share data is estimated and may not be exact. Investors should conduct their own due diligence before making any investment decisions.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About OPTIMIZERx Corp
Exchange NASDAQ | Headquaters Waltham, MA, United States | ||
IPO Launch date 1996-10-22 | President & CEO Mr. Stephen L. Silvestro | ||
Sector Healthcare | Industry Health Information Services | Full time employees 128 | Website https://www.optimizerx.com |
Full time employees 128 | Website https://www.optimizerx.com | ||
OptimizeRx Corporation operates as a digital healthcare technology company. The company offers Dynamic Audience Activation Platform, which generates dynamic audiences with predictive analytics through machine learning methods; Micro-Neighborhood Targeting, which creates consumer audiences using a privacy-first process; Profiler, which provides insights into its customers' target consumers; banner messages, including brand messaging, therapeutic support messaging, affordability messaging, HUB awareness, limited distribution drug information, and patient support program messaging through healthcare professionals; and media execution solutions, which deliver messages through consumer omnichannel network, including through programmatic display, programmatic connected television/over-the-top, programmatic social media, addressable television, digital out-of-home, programmatic audio, and email/direct mail. It also offers pharmacy alerts, which flag pharmacies that have prescription medications in stock; and financial messaging solutions, which provide prescribers visibility to branded copay offers for patients directly within electronic health record systems and ePrescribing platforms. The company was founded in 2006 and is based in Waltham, Massachusetts.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.